BridgeBio Pharma secures $299m in funding to accelerate genetic disease drug development
BridgeBio Pharma, a leading clinical-stage biopharma company specialising in treatments for genetic diseases, has raised $299.2 million in a new funding round. The California-based firm ... Read More
KKR to buy 60% stake in environmental services provider Ramky Enviro
Global investment firm KKR has agreed to acquire a stake of 60% in Indian environmental services provider Ramky Enviro Engineers (REEL) from Ramky Group for ... Read More
Unilever to divest Spreads business to KKR in €6.825bn deal
Food acquisition news : Unilever, a British-Dutch multinational consumer goods firm has struck a deal to divest its global spreads business to investment firm KKR ... Read More